TSE:TBP's free cash flow for Q3 2022 was C$-873.53K. For the 2022 fiscal year, TSE:TBP's free cash flow was decreased by C$-5.67M and operating cash flow was C$-873.53K. See a summary of the company’s cash flow.

Cash Flow	TTM	Nov 21	Nov 20	Nov 19	Nov 18	Nov 17
Operating Cash Flow	C$ -8.18M	C$ -25.28M	C$ -19.64M	C$ -17.34M	C$ -9.51M	C$ -3.89M
Investing Cash Flow	C$ -683.75K	C$ -2.12M	C$ -3.42M	C$ -3.69M	C$ -2.13M	C$ -750.00K
Financing Cash Flow	C$ 779.43K	C$ 29.78M	C$ 23.52M	C$ 9.73M	C$ 23.03M	C$ 5.62M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	C$ 10.78M	C$ 4.89M	C$ -3.87M	C$ 2.04M	C$ 13.59M	C$ 2.19M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	C$ 1.13M	C$ 26.31M	C$ 24.65M	C$ 8.31M	C$ 11.50M	C$ 1.48M
Issuance Of Debt	C$ -876.60K	C$ 1.00M	-	-	-	-
Repayment Of Debt	C$ -1.45M	C$ -2.00M	-	-	-	-
Free Cash Flow	C$ -8.22M	C$ -25.28M	C$ -19.61M	C$ -17.60M	C$ -9.51M	C$ -4.64M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in CAD

Tetra Bio-Pharma Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing